Teva Pharmaceutical Indus (NYSE:TEVA) 公布了第四季度每股收益为$0.71，高于分析师普遍预期的$0.70，超出1.43个百分点。与去年同期每股收益$1.00相比下降了29%。公司报告季度销售额为42亿美元，高于分析师普遍预期的41.3亿美元，超出1.69个百分点。与去年同期销售额44.6亿美元相比下降了5.77%。
以上内容来自Benzinga Earnings专栏，原文如下：
Teva Pharmaceutical Indus (NYSE:TEVA) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.70 by 1.43 percent. This is a 29 percent decrease over earnings of $1.00 per share from the same period last year. The company reported quarterly sales of $4.20 billion which beat the analyst consensus estimate of $4.13 billion by 1.69 percent. This is a 5.77 percent decrease over sales of $4.46 billion the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。